Blue Trust’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
Other funds holding ANAB
Blue Trust's ANAB Position: Q3 2026 in Review
Blue Trust held its AnaptysBio (ANAB) position steady in Q3 2026 at 19 shares worth $955. The position accounts for ﹤0.01% of the portfolio, ranked #2179.
Blue Trust first reported a position in ANAB in Q2 2022 and has held it in 11 quarters since. The position peaked at $1.28K in Q2 2026. 165 funds tracked by Wall St. Rank hold ANAB as of Q3 2026.
- Blue Trust held 19 shares of AnaptysBio worth $955 as of Q3 2026.
- Blue Trust left its AnaptysBio share count unchanged in Q3 2026.
- AnaptysBio made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #2179 holding.
- Blue Trust first reported a position in AnaptysBio in Q2 2022 and has held it in 11 quarters since.
- Blue Trust's AnaptysBio position peaked at $1.28K in Q2 2026.
- 165 funds tracked by Wall St. Rank held AnaptysBio as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.